HHE Pathology 2019 | Page 7

regions can make it difficult to accumulate sufficient quantity of data for a reliable audit. A solution is to accumulate data over longer periods of time; perhaps two years instead of annually. CRIS did not capture all of the information needed, resulting in a reliance on paper records being transcribed for analysis electronically. This is a very time-consuming process and can result in possible transcription errors. Another potential problem with paper records is inaccurate or inconsistent naming conventions, especially for body regions. For instance, some technologists might write ‘lumbar spine’ and others ‘L-spine’, meaning that any automated analysis will treat these as separate. A significant amount of manual interrogation of data is therefore required to ensure data is recorded correctly and consistently, a very time consuming and inefficient process. Following on from the initial audit, we have been able to implement improved local systems to facilitate routine audit in a more efficient manner. These include collecting SPECT/CT over a two-year audit period to ensure enough data are included to be confident in it. Additional CRIS entries have been found to record dose mode, and a free text box is used to record body region, removing the need for paper records. Principal technologists also developed guidance on naming conventions to help achieve consistency and reduce the burden of manually correcting entries retrospectively. Finally, a monthly CRIS download is performed and reviewed by a nuclear medicine assistant practitioner to check adherence to naming conventions, confirm the scanner used and body region, and check any ambiguous or suspicious data. These monthly checks are essentially a tidy and quality check of the data, with monthly numbers being found to be more manageable. Therefore the system is not fully automated, but much less labour intensive than previously and with practices improving over time, routine audit can be made sustainable in the long term. In summary, it is certainly possible to develop systems for patient dosimetry audit in nuclear medicine CT, but auditors must be aware of the additional complications that might not be familiar to those primarily working in diagnostic radiology. Careful thought is needed on how these complications will be managed in an efficient way to allow for ongoing audit. The challenges were much more practical than analytical in this case (radiotherapy planning CT), meaning that most of the work involved in setting up local audit is in finding efficient ways to reliably collect data on a large scale Radiotherapy planning CT For radiotherapy planning CT, data were analysed for adult patients on two Philips Brilliance Big Bore References 1 Ionising Radiation (Medical Exposure) Regulations 2017. Statutory Instruments 2017, No. 1322. London, HMSO. 2 IPEM. Guidance on the Establishment and Use of Diagnostic Reference Levels for Medical X-ray Examinations. Institute of Physics and Engineering in Medicine. Report Number 88, 2004. 3 Hart D, Hillier MC, Shrimpton, PC. Doses to patients from radiographic and fuoroscopic X-ray imaging procedures in the UK - 2010 review. Health Protection Agency. Report Number: HPA-CRCE-034, 2012. 4 Shrimpton PC et al. Doses from computed tomography (CT) examinations in the UK – 2011 review. Public Health England. Report Number: PHE-CRCE-013, 2014. 5 Public Health England, 2016. Diagnostic Radiology: National Diagnostic Reference levels (NDRLs). www.gov.uk/ government/publications/ diagnostic-radiology-national- diagnostic-reference-levels-ndrls/ ndrl (published 15 November 2018) (accessed August 2019). 6 Charnock P, Moores BM, Wilde R. Establishing local and regional DRLs by means of electronic radiographical X-ray examination records. Radiat Prot Dosimetry 2013;157:62–72. 7 Charnock P et al. Establishment of a comprehensive set of regional DRLs for CT by means of electronic X-ray examination records. Radiat Prot Dosimetry 2015;163:509–20. 8 Etard C et al. National survey of patient doses from whole-body FDG PET-CT examinations in France in 2011. Radiat Prot Dosimetry 2012;152:334–8. 9 Jallow N et al. Diagnostic reference levels of CT radiation dose in whole-body PET/CT. J Nucl Med 2016;57:238–41. 10 Alkhybari EM et al. Determining and updating PET/ CT and SPECT/CT diagnostic reference levels: A systematic review. Radiat Prot Dosimetry 7 HHE 2019 | hospitalhealthcare.com CT scanners over the 2017 calendar year. The task was found to be very similar to that for diagnostic radiology CT, in that there were no separate dose modes and the protocols were standardised in terms of the body region scanned. Once the data were acquired, it was therefore simple to analyse using established methods, but there were challenges with the practicalities of acquiring the data. Radiotherapy systems are not interfaced with CRIS, as the scans are not taken to be reported on but to facilitate treatment. Instead, radiotherapy systems include treatment planning and record and verify systems. These systems do not appear to be designed with patient dosimetry audit in mind. It is a simple matter to look up the records of individual patients, but these systems are not set up for outputting large-scale patient dose information in the format facilitating audit (such as a spreadsheet). So a solution is needed to avoid manually combing individual patient records one at a time for data, an extremely inefficient proposal. An initial audit showed that radiographers had been keeping paper records of all CT scan dose information (largely for historical reasons) and so these data were transcribed for analysis. These records did not specify the protocol used but the examination purpose and so there could be issues with naming conventions, with different description actually referring to the same type of scan. Knowing the protocol would allow such cases to be identified and merged for more reliable audit. To help resolve this, a simple in-house software was developed to search the data and extract the protocol information based on keywords in examination information. This allowed protocols to be matched against the manual descriptions and in discussion with radiographers, datasets can be merged where similar protocols are used. The hope in future is that the in-house software will be usable more widely to allow the need for manual transcription and interrogation of the data to be reduced and the data simply extracted. So as with nuclear medicine CT, we have been able to implement a system for local audit of radiotherapy planning CT (and incidentally demonstrate compliance with NDRLs was being achieved), although with some room for further improvement to automate the process. The challenges were much more practical than analytical in this case, meaning that most of the work involved in setting up local audit is in finding efficient ways to reliably collect data on a large scale and so this may have to be carefully considered when implementing audit elsewhere. 2018;182:532–45. 11 Dennis JL, Gemmell A, Nicol AJ. Optimization of the CT component of SPECT-CT and establishment of local CT diagnostic reference levels for clinical practice. Nucl Med Commun 2018;39:493–9. 12 Connor SO, Mc Ardle O, Mullaney L. Establishment of national diagnostic reference levels for breast cancer CT protocols in radiation therapy. Br J Radiol 2016;89:20160428. 13 Iball GR et al. A national survey of computed tomography doses in hybrid PET-CT and SPECT-CT examinations in the UK. Nucl Med Commun 2017;38(6):459–70. 14 Wood TJ et al. IPEM topical report: the first UK survey of dose indices from radiotherapy treatment planning computed tomography scans for adult patients. Phys Med Biol 2018;63:185008. 15 Gardner M et al. Patient dosimetry audit for establishing local diagnostic reference levels for nuclear medicine CT. Br J Radiol 2017;90:20160850. 16 Bebbington N et al. UK national reference doses for CT scans performed in hybrid imaging studies. J Nucl Med 2016;57(no. supplement 2):594.